Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.

Lin CC, Hou HA, Chou WC, Kuo YY, Wu SJ, Liu CY, Chen CY, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Hsu SC, Ko BS, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 Aug;89(8):E109-15. doi: 10.1002/ajh.23734. Epub 2014 Apr 28.

PMID:
24723457
[PubMed - indexed for MEDLINE]
2.

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.

Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV.

Blood. 2012 Oct 18;120(16):3173-86. doi: 10.1182/blood-2012-05-430876. Epub 2012 Jul 23.

PMID:
22826563
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.

Lin CC, Hou HA, Chou WC, Kuo YY, Liu CY, Chen CY, Lai YJ, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Ko BS, Wu SJ, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 Feb;89(2):137-44. doi: 10.1002/ajh.23596. Epub 2013 Nov 20.

PMID:
24115220
[PubMed - indexed for MEDLINE]
4.

Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts.

Seo JY, Lee KO, Kim SH, Kim K, Jung CW, Jang JH, Kim HJ.

Ann Hematol. 2014 Apr;93(4):603-8. doi: 10.1007/s00277-013-1915-x. Epub 2013 Oct 19.

PMID:
24141330
[PubMed - indexed for MEDLINE]
5.

Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts.

Cui R, Gale RP, Xu Z, Qin T, Fang L, Zhang H, Pan L, Zhang Y, Xiao Z.

Leuk Res. 2012 Nov;36(11):1428-33. doi: 10.1016/j.leukres.2012.08.015. Epub 2012 Aug 23.

PMID:
22921018
[PubMed - indexed for MEDLINE]
6.

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, Travaglino E, Groves MJ, Godfrey AL, Ambaglio I, Gallì A, Da Vià MC, Conte S, Tauro S, Keenan N, Hyslop A, Hinton J, Mudie LJ, Wainscoat JS, Futreal PA, Stratton MR, Campbell PJ, Hellström-Lindberg E, Cazzola M; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium and of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative.

Blood. 2011 Dec 8;118(24):6239-46. doi: 10.1182/blood-2011-09-377275. Epub 2011 Oct 12.

PMID:
21998214
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value.

Patnaik MM, Lasho TL, Hodnefield JM, Knudson RA, Ketterling RP, Garcia-Manero G, Steensma DP, Pardanani A, Hanson CA, Tefferi A.

Blood. 2012 Jan 12;119(2):569-72. doi: 10.1182/blood-2011-09-377994. Epub 2011 Nov 17.

PMID:
22096241
[PubMed - indexed for MEDLINE]
Free Article
8.

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution.

Wu SJ, Kuo YY, Hou HA, Li LY, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Lin CT, Chen CY, Chou WC, Yao M, Huang SY, Ko BS, Tang JL, Tsay W, Tien HF.

Blood. 2012 Oct 11;120(15):3106-11. doi: 10.1182/blood-2012-02-412296. Epub 2012 Aug 29.

PMID:
22932795
[PubMed - indexed for MEDLINE]
Free Article
9.

Development of a high-resolution melting analysis for the detection of the SF3B1 mutations.

Yang J, Qian J, Lin J, Yang XF, Qian W, Chen Q, Yao DM, Wang CZ, Chen XX, Xiao GF, Ma YJ.

Genet Test Mol Biomarkers. 2013 Apr;17(4):342-7. doi: 10.1089/gtmb.2012.0364. Epub 2013 Feb 7.

PMID:
23390883
[PubMed - indexed for MEDLINE]
10.

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.

Broséus J, Alpermann T, Wulfert M, Florensa Brichs L, Jeromin S, Lippert E, Rozman M, Lifermann F, Grossmann V, Haferlach T, Germing U, Luño E, Girodon F, Schnittger S; MPN and MPNr-EuroNet (COST Action BM0902).

Leukemia. 2013 Sep;27(9):1826-31. doi: 10.1038/leu.2013.120. Epub 2013 Apr 18.

PMID:
23594705
[PubMed - indexed for MEDLINE]
11.

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, Godfrey AL, Rapado I, Cvejic A, Rance R, McGee C, Ellis P, Mudie LJ, Stephens PJ, McLaren S, Massie CE, Tarpey PS, Varela I, Nik-Zainal S, Davies HR, Shlien A, Jones D, Raine K, Hinton J, Butler AP, Teague JW, Baxter EJ, Score J, Galli A, Della Porta MG, Travaglino E, Groves M, Tauro S, Munshi NC, Anderson KC, El-Naggar A, Fischer A, Mustonen V, Warren AJ, Cross NC, Green AR, Futreal PA, Stratton MR, Campbell PJ; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium.

N Engl J Med. 2011 Oct 13;365(15):1384-95. doi: 10.1056/NEJMoa1103283. Epub 2011 Sep 26.

PMID:
21995386
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Gene mutation and myelodysplastic syndromes with ring sideroblast excess].

Meng FK, Huang LF, Zhou JF, Sun HY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Aug;21(4):1088-90. doi: 10.7534/j.issn.1009-2137.2013.04.053. Review. Chinese.

PMID:
23998618
[PubMed - indexed for MEDLINE]
13.

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.

Ambaglio I, Malcovati L, Papaemmanuil E, Laarakkers CM, Della Porta MG, Gallì A, Da Vià MC, Bono E, Ubezio M, Travaglino E, Albertini R, Campbell PJ, Swinkels DW, Cazzola M.

Haematologica. 2013 Mar;98(3):420-3. doi: 10.3324/haematol.2012.077446. Epub 2013 Jan 8.

PMID:
23300182
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia.

Wang C, Sashida G, Saraya A, Ishiga R, Koide S, Oshima M, Isono K, Koseki H, Iwama A.

Blood. 2014 May 22;123(21):3336-43. doi: 10.1182/blood-2013-12-544544. Epub 2014 Apr 15.

PMID:
24735968
[PubMed - indexed for MEDLINE]
15.

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C, Della Valle V, Couronné L, Scourzic L, Chesnais V, Guerci-Bresler A, Slama B, Beyne-Rauzy O, Schmidt-Tanguy A, Stamatoullas-Bastard A, Dreyfus F, Prébet T, de Botton S, Vey N, Morgan MA, Cross NC, Preudhomme C, Birnbaum D, Bernard OA, Fontenay M; Groupe Francophone des Myélodysplasies.

Blood. 2012 Apr 5;119(14):3211-8. doi: 10.1182/blood-2011-12-400994. Epub 2012 Feb 17.

PMID:
22343920
[PubMed - indexed for MEDLINE]
Free Article
16.

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.

Patnaik MM, Lasho TL, Finke CM, Hanson CA, Hodnefield JM, Knudson RA, Ketterling RP, Pardanani A, Tefferi A.

Am J Hematol. 2013 Mar;88(3):201-6. doi: 10.1002/ajh.23373. Epub 2013 Jan 18.

PMID:
23335386
[PubMed - indexed for MEDLINE]
17.

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP.

Blood. 2012 Apr 5;119(14):3203-10. doi: 10.1182/blood-2011-12-399774. Epub 2012 Feb 9.

PMID:
22323480
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.

Cazzola M, Rossi M, Malcovati L; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative.

Blood. 2013 Jan 10;121(2):260-9. doi: 10.1182/blood-2012-09-399725. Epub 2012 Nov 16. Review.

PMID:
23160465
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications.

Damm F, Thol F, Kosmider O, Kade S, Löffeld P, Dreyfus F, Stamatoullas-Bastard A, Tanguy-Schmidt A, Beyne-Rauzy O, de Botton S, Guerci-Bresler A, Göhring G, Schlegelberger B, Ganser A, Bernard OA, Fontenay M, Heuser M.

Leukemia. 2012 May;26(5):1137-40. doi: 10.1038/leu.2011.321. Epub 2011 Nov 8. No abstract available.

PMID:
22064355
[PubMed - indexed for MEDLINE]
20.

Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.

Je EM, Yoo NJ, Kim YJ, Kim MS, Lee SH.

Int J Cancer. 2013 Jul;133(1):260-5. doi: 10.1002/ijc.28011. Epub 2013 Feb 5.

PMID:
23280334
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk